COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Geranium Oil and Its Components for the Relief of Numbness-OB 100

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01022437
Recruitment Status : Completed
First Posted : December 1, 2009
Last Update Posted : December 18, 2015
Information provided by (Responsible Party):
Frank Greenway, Pennington Biomedical Research Center

Brief Summary:
This study is designed to evaluate the effectiveness of geranium oil and its components in the relief of numbness and the restoration of sensations.

Condition or disease Intervention/treatment Phase
Nerve Conduction Numbness Other: Geranium Oil with component PN-34 Not Applicable

Detailed Description:
This is a pilot study to define the time course, the incidence of sensation restoration and the improvement in nerve conduction in people with numbness by using topical geranium oil.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 13 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Geranium Oil and Its Components for the Relief of Numbness-OB 100
Study Start Date : December 2008
Actual Primary Completion Date : October 2011
Actual Study Completion Date : October 2011

Arm Intervention/treatment
Experimental: Geranium Oil and component PN-34 Other: Geranium Oil with component PN-34
Geranium oil as a topical application to the body that is numb, time to determine how long it takes for the feeling to return, if it does so, and if the return of feeling is maintained by daily topical application of oil over 12 weeks. This including the process of absorption, distribution and localization.

Primary Outcome Measures :
  1. Response to numbness relief and restoration of sensation [ Time Frame: 12 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 18 years of age or older
  • Neuropathy with the inability to feel touch in a standard nylon filament test
  • Signed informed consent

Exclusion Criteria:

  • Pregnant or nursing
  • Known allergies to geranium oil or geranium oil fractions
  • Open sore in the area of numbness
  • Migraine headaches or headaches to strong smells

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01022437

Layout table for location information
United States, Louisiana
Penningto Biomedical Research Center
Baton Rouge, Louisiana, United States, 70809
Sponsors and Collaborators
Pennington Biomedical Research Center
Layout table for investigator information
Principal Investigator: Alok Gupta, MD Pennington Biomedical Research Center
Layout table for additonal information
Responsible Party: Frank Greenway, Clinical Medical Doctor, Pennington Biomedical Research Center Identifier: NCT01022437    
Other Study ID Numbers: PBRC 28041
First Posted: December 1, 2009    Key Record Dates
Last Update Posted: December 18, 2015
Last Verified: December 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Somatosensory Disorders
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms